|
Aug 2
|
Glaukos Corporation (NYSE:GKOS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
|
|
Jul 31
|
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
|
|
Jul 30
|
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 30
|
Glaukos: Q2 Earnings Snapshot
|
|
Jul 30
|
Glaukos Announces Second Quarter 2025 Financial Results
|
|
Jun 27
|
Glaukos gains EU certification for iStent infinite and other MIGS devices
|
|
Jun 25
|
Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies
|
|
Jun 25
|
NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record
|
|
Jun 25
|
Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell
|
|
Jun 16
|
What Makes Glaukos (GKOS) a New Buy Stock
|
|
Jun 11
|
Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect?
|
|
Apr 24
|
Earnings Preview: Mettler-Toledo (MTD) Q1 Earnings Expected to Decline
|
|
Apr 23
|
Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
|
|
Apr 10
|
Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?
|
|
Apr 9
|
Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30
|
|
Apr 8
|
What Makes Glaukos Corporation (GKOS) a Compelling Stock?
|
|
Apr 1
|
The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals
|
|
Mar 31
|
3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space
|
|
Mar 13
|
Here's Why You Should Retain Glaukos Stock in Your Portfolio
|
|
Mar 11
|
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
|